印刷

診療科・部門紹介
診療科・部門紹介

肝・胆・膵内科

肝・胆・膵内科

最終更新日 : 2024年11月21日

診療科の特徴診療実績スタッフ紹介治験・臨床試験|研究業績(論文発表)|専門研修のご案内

研究業績・論文発表(過去5年間)

2019年

(筆頭論文:全著者を記載)

  1. Sasaki T, Kanata R, Yamada I, Matsuyama M, Ozaka M, Sasahira N.
    Improvement of treatment outcomes for metastatic pancreatic cancer: A real-world data analysis.
    In Vivo. 2019 Jan-Feb;33(1):271-276

(共著論文:筆頭著者, 第2著者, 当科著者, 最終著者のみ記載)

  1. Ioka T, Ueno M, Sasahira N, Hyodo I, et al.
    TAS-118 (S-1 plus leucovorin) versus S-1 in patients with gemcitabine-refractory advanced pancreatic cancer: a randomised, open-label, phase 3 study (GRAPE trial).
    Eur J Cancer. 2019 Jan,106:78-88
  2. Kuwai T, Yamaguchi T, Sasaki T, Saida Y, et al.
    Factors related to difficult self-expandable metallic stent placement for malignant colonic obstruction: A post hoc analysis of a multicenter study across Japan.
    Dig Endosc. 2019 Jan;31(1):51-58
  3. Shirasu H, Todaka A, Ozaka M, Fukutomi A, et al.
    The impact of UGT1A1 genetic polymorphism on toxicity in unresectable pancreatic cancer patients undergoing FOLFIRINOX.
    Cancer Sci. 2019 Feb;110(2):707-716
  4. Matsumoto I, Kamei K, Ozaka M, Fukutomi A, et al.
    FOLFIRINOX for locally advanced pancreatic cancer: Results and prognostic factors of subset analysis from a nation-wide multicenter observational study in Japan.
    Pancreatology. 2019 Mar;19(2):296-301
  5. Yoshida T, Hijioka S, Ishii H, Mizuno N, et al.
    Surgery for pancreatic neuroendocrine tumor G3 and carcinoma G3 should be considered separately.
    Ann Surg Oncol. 2019 May;26(5):1385-1393
  6. Kobayashi S, Ueno M, Ozaka M, Fukutomi A, et al.
    Influence of initial dose intensity on efficacy of FOLFIRINOX in patients with advanced pancreatic cancer.
    Oncotarget. 2019;10(19):1775-1784
  7. Nishida T, Sakai Y, Ozaka M, Hirota S, et al; members of the STAR ReGISTry Study Group.
    Adherence to the guidelines and the pathological diagnosis of high-risk gastrointestinal stromal tumors in the real world.
    Gastric Cancer. 2020 Jan;23(1):118-125
  8. Kudo M, Ueshima K, Ishii H, Nishida N, et al.
    Lenvatinib as an initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria and Child-Pugh A liver function: A proof-of-concept study.
    Cancers (Basel). 2019 Jul 31;11(8)
  9. Doi T, Kurokawa Y, Ozaka M, Nishida T, et al.
    Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm trial.
    Eur J Cancer. 2019 Nov;121:29-39
  10. Morizane C, Okusaka T, Ozaka M, Furuse J, et al; members of the Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG).
    Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial.
    Ann Oncol. 2019 Dec 1;30(12):1950-1958

2020年

(筆頭論文)

  1. Sasaki T, Ishibashi R, Yoshida S, Fujisawa T, Shinagawa H, Gon C, Nakai Y, Sasahira N, Saida Y, Isayama H.
    Comparing the mechanical properties of a self-expandable metallic stent for colorectal obstruction: a proposed measurement method of axial force using a new measurement machine.
    J Hepatobiliary Pancreat Sci. 2020 Sep;27(9):663-664
  2. Sawada M, Kasuga A, Mie T, Furukawa T, Taniguchi T, Fukuda K, Yamada Y, Takeda T, Kanata R, Matsuyama M, Sasaki T, Ozaka M, Sasahira N.
    Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer.
    BMC Cancer. 2020 May 20;20(1):449
  3. Sasaki T, Mie T, Takeda T, Nakagawa S, Ono Y, Takahashi Y, Sasahira N.
    Percutaneous insertion of a jejunal tube via the collapsed blind end of elevated jejunum by a balloon puncturing method assisted by a balloon enteroscope.
    J Hepatobiliary Pancreat Sci. 2020 Sep;27(9):663-664
  4. Takeda T, Sasaki T, Inoue Y, Mie T, Furukawa T, Kanata R, Kasuga A, Matsuyama M, Ozaka M, Takahashi Y, Saiura A, Sasahira N.
    Comprehensive comparison of clinicopathological characteristics, treatment, and prognosis of borderline resectable pancreatic cancer according to tumor location.
    Pancreatology. 2020 Sep;20(6):1123-1130
  5. Sasaki T, Takeda T, Sasahira N.
    Double stenting with EUS-CDS using a new anti-reflux metal stent for combined malignant biliary and duodenal obstruction.
    J Hepatobiliary Pancreat Sci. 2020 Nov;27(11):e15-e16
  6. Fukuda K, Sasaki T, Hirasawa T, Matsueda K, Nakao E, Mie T, Furukawa T, Yamada Y, Takeda T, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    A case of percutaneous transhepatic portal vein stent placement and endoscopic injection sclerotherapy for duodenal variceal rupture occurring during chemotherapy for unresectable perihilar cholangiocarcinoma.
    Clin J Gastroenterol. 2020 Dec;13(6):1150-1156
  7. Mie T, Sasaki T, Kanata R, Furukawa T, Takeda T, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    Diagnostic yield of endoscopic ultrasound-guided tissue acquisition for small solid pancreatic lesions.
    Endosc Int Open. 2020 Oct;8(10):E1359-E1364
  8. Takeda T, Sasaki T, Mie T, Furukawa T, Kanata R, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    Novel risk factors for recurrent biliary obstruction and pancreatitis after metallic stent placement in pancreatic cancer.
    Endosc Int Open. 2020 Nov;8(11):E1603-E1610

(共著論文)

  1. Nishida T, Sakai Y, Ozaka M, Hirota S, et al; members of the STAR ReGISTry Study Group.
    Adherence to the guidelines and the pathological diagnosis of high-risk gastrointestinal stromal tumors in the real world.
    Gastric Cancer. 2020 Jan;23(1):118-125
  2. Kobayashi S, Ueno M, Ozaka M, Yamada I, Sasaki T, Sasahira N, Morimoto M, et al.
    A multicenter retrospective study of gemcitabine plus nab-paclitaxel for elderly patients with advanced pancreatic cancer.
    Pancreas. 2020 Feb;49(2):187-192
  3. Lin Y, Nakatochi M, Ozaka M, Sasaki T, Matsuyama M, Sasahira N, Matsuo K, et al.
    Genome-wide association meta-analysis identifies GP2 gene risk variants for pancreatic cancer.
    Nat Commun. 2020 Jun 24;11(1):3175
  4. Uesato Y, Sasahira N, Ozaka M, Sasaki T, Zembutsu H, et al.
    Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis.
    PLoS One. 2020 Jul 2;15(7):e0235623
  5. Fujimori M, Sato A, Ozaka M, Uchitomi Y, et al.
    Integrated communication support program for oncologists, caregivers and patients with rapidly progressing advanced cancer to promote patient-centered communication: J-SUPPORT 1904 study protocol for a randomised controlled trial.
    BMJ Open. 2020 Sep 23;10(9):e036745
  6. Kobayashi N, Omae K, Ozaka M, Fukutomi A, et al.
    FOLFIRINOX as second-line chemotherapy for advanced pancreatic cancer: A subset analysis of data from a nationwide multicenter observational study in Japan.
    Pancreatology. 2020 Oct;20(7):1519-1525
  7. Ueno M, Nakamori S, Ozaka M, Ioka T, et al.
    nal-IRI+5-FU/LV versus 5-FU/LV in post-gemcitabine metastatic pancreatic cancer: Randomized phase 2 trial in Japanese patients.
    Cancer Med. 2020 Dec;9(24):9396-9408
  8. Ueno M, Ikeda M, Sasaki T, Morizane C, et al.
    Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results.
    BMC Cancer. 2020 Nov 16;20(1):1105

2021年

(筆頭論文)

  1. Sasaki T, Ishibashi R, Yoshida S, Fujisawa T, Shinagawa H, Gon C, Nakai Y, Sasahira N, Saida Y, Isayama H.
    Comparing the mechanical properties of a self-expandable metallic stent for colorectal obstruction: a proposed measurement method of axial force using a new measurement machine.
    Dig Endosc. 2021 Jan;33(1):170-178.
  2. Sasaki T, Sasahira N.
    Direct Insertion of a Short-Type Single-Balloon Enteroscope and Using a Stent Retriever to Treat Difficult Bile Duct Stones in Surgically Altered Anatomy.
    Clin Endosc. 2021 Nov;54(6):937-938.
  3. Sasaki T, Takeda T, Yasue C, Tokura J, Ide D, Saito S, Sasahira N.
    Endoscopic removal of two duodenal stents that had migrated into the colon, using the invagination method.
    Endoscopy. 2021 Jun;53(6):E209-E210.
  4. Kasuga A, Semba T, Sato R, Nobusue H, Sugihara E, Takaishi H, Kanai T, Saya H, Arima Y.
    Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice.
    Cancer Sci. 2021 May;112(5):1822-1838.
  5. Furukawa T, Sasaki T, Takeda T, Mie T, Kanata R, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    Two case reports of brain metastases in patients with pancreatobiliary neuroendocrine carcinoma.
    Clin J Gastroenterol. 2021 Feb;14(1):386-390
  6. Fukuda K, Sasaki T, Sasahira N.
    Portal vein guidewire insertion: Rare complication of wire-guided cannulation during single-balloon enteroscopy-assisted endoscopic retrograde cholangiopancreatography.
  7. Dig Endosc. 2021 Jan;33(1):e3-e4.
    7. Takeda T, Sasaki T, Fukuda K, Mie T, Furukawa T, Yamada Y, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    Risk factors for gemcitabine plus nab-paclitaxel-induced interstitial lung disease in pancreatic cancer patients.
    Int J Clin Oncol. 2021 Mar;26(3):543-551.
  8. Takeda T, Sasaki T, Mie T, Furukawa T, Kanata R, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    The safety and efficacy of self-expandable metallic stent placement for malignant biliary obstruction with surgically altered anatomy.
    Scand J Gastroenterol. 2021 Jan;56(1):94-102
  9. Sasaki T, Mie T, Sasahira N.
    Blind Spot of Enteral Stenting for Malignant Duodenal Obstruction due to Colon Cancer: A Rare Case of Duodenocolonic Fistula.
    Clin Endosc. 2021 May;54(3):443-444.
  10. Kanata R, Sasaki T, Matsuyama M, Ishigaki K, Yamada I, Ozaka M, Takano K, Takazawa Y, Ishizuka N, Sasahira N.
    Prospective study of EUS-guided tissue acquisition with a 20G core biopsy needle with a forward bevel for solid pancreatic mas.
    Medicine (Baltimore). 2021 Jan 15;100(2):e24193.
  11. Takeda T, Sasaki T, Mie T, Furukawa T, Yamada Y, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    The impact of body composition on short-term outcomes of neoadjuvant chemotherapy with gemcitabine plus S-1 in patients with resectable pancreatic cancer.
    Jpn J Clin Oncol. 2021 Apr 1;51(4):604-611.
  12. Furukawa T, Ozaka M, Takamatsu M, Takazawa Y, Inamura K, Inoue Y, Mie T, Takeda T, Kanata R, Kasuga A,
    Matsuyama M, Sasaki T, Takahashi Y, Sasahira N.
    Ki-67 Labeling Index Variability Between Surgically Resected Primary and Metastatic Hepatic Lesions of Gastroenteropancreatic Neuroendocrine Neoplasms.
    Int J Surg Pathol. 2021 Aug;29(5):475-481.
  13. Mie T, Sasaki T, Takeda T, Furukawa T, Yamada Y, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    A case of endoscopic ultrasound-guided hepaticogastrostomy for obstructive jaundice caused by intraductal papillary mucinous neoplasm-associated pancreatobiliary fistula.
    Clin J Gastroenterol. 2021 Jun;14(3):893-898.
  14. Takeda T, Sasaki T, Mie T, Furukawa T, Yamada Y, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    The prognostic impact of tumour location and first-line chemotherapy regimen in locally advanced pancreatic cancer.
    Jpn J Clin Oncol. 2021 Apr 30;51(5):728-736.
  15. Mie T, Sasaki T, Kanata R, Furukawa T, Takeda T, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    Comparison of Endoscopic Ultrasound-Guided Tissue Acquisition Using a 20-Gauge Menghini Needle with a Lateral Forward Bevel and a 22-Gauge Franseen Needle A Single-Center Large Cohort Study.
    Clin Endosc. 2021 Sep;54(5):730-738.
  16. Takeda T, Sasaki T, Mie T, Furukawa T, Yamada Y, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    Improved prognosis of pancreatic cancer patients with peritoneal metastasis.
    Pancreatology. 2021 Aug;21(5):903-911.
  17. Takeda T, Sasaki T, Suzumori C, Mie T, Furukawa T, Yamada Y, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy.
    Int J Clin Oncol. 2021 Jul;26(7):1293-1303.
  18. Yamada Y, Sasaki T, Takeda T, Mie T, Furukawa T, Kasuga A, Matsuyama M, Ozaka M, Igarashi Y, Sasahira N.
    A novel laser-cut fully-covered metal stent with anti-reflux valve in patients with malignant distal biliary obstruction refractory to conventional covered metal stent.
    J Hepatobiliary Pancreat Sci. 2021 Jul;28(7):563-571.
  19. Mie T, Sasaki T, Takeda T, Fukuda K, Furukawa T, Yamada Y, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    Comparison of Treatment Outcomes Between Gemcitabine With Nab-Paclitaxel and Modified FOLFIRINOX for First-Line Chemotherapy in Metastatic and Recurrent Pancreatic Cancer: Propensity Score Matching.
    Pancreas. 2021 Apr 1;50(4):595-601.
  20. Mie T, Sasaki T, Takeda T, Okamoto T, Mori C, Furukawa T, Yamada Y, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    Treatment outcomes of erlotinib plus gemcitabine as late-line chemotherapy in unresectable pancreatic cancer.
    Jpn J Clin Oncol. 2021 Aug 30;51(9):1416-1422.
  21. Furukawa T, Sasaki T, Ono Y, Kawano F, Takamatsu M, Mori C, Mie T, Yamada Y, Okamoto T, Takeda T, Kasuga A, Matsuyama M, Ozaka M, Takahashi Y, Sasahira N.
    A case of necrotic enteritis during neoadjuvant chemotherapy with gemcitabine and S-1 for resectable pancreatic ductal adenocarcinoma.
    Clin J Gastroenterol. 2021 Oct;14(5):1571-1577.
  22. Sasaki T, Takeda T, Okamoto T, Ozaka M, Sasahira N.
    Chemotherapy for Biliary Tract Cancer in 2021.
    J Clin Med. 2021 Jul 14;10(14):3108.
  23. Takeda T, Sasaki T, Okamoto T, Sasahira N.
    Endoscopic Double Stenting for the Management of Combined Malignant Biliary and Duodenal Obstruction.
    J Clin Med. 2021 Jul 29;10(15):3372.
  24. Okamoto T, Sasaki T, Nishimura N, Takamatsu M, Mori C, Mie T, Furukawa T, Yamada Y, Takeda T, Kasuga A, Matsuyama M, Ozaka M, Maruyama D, Sasahira N.
    Pancreatic follicular lymphoma: a report of two cases and literature review.
    Clin J Gastroenterol. 2021 Dec;14(6):1756-1765.
  25. Sasaki T, Yoshida S, Isayama H, Narita A, Yamada T, Enomoto T, Sumida Y, Kyo R, Kuwai T, Tomita M, Moroi R, Shimada M, Hirata N, Saida Y.
    Short-Term Outcomes of Colorectal Stenting Using a Low Axial Force Self-Expandable Metal Stent for Malignant Colorectal Obstruction: A Japanese Multicenter Prospective Study.
    J Clin Med. 2021 Oct 26;10(21):4936.

(共著論文)

  1. Okano N, Furuse J, Ozaka M, Okusaka T, et al.
    Multicenter Phase II Trial of Axitinib Monotherapy for Gemcitabine-Based Chemotherapy Refractory Advanced Biliary Tract Cancer (AX-BC Study).
    Oncologist. 2021 Feb;26(2):97-e201.
  2. Inoue Y, Saiura A, Sasaki T, Ozaka M, Sasahira N, Takahashi Y, et al.
    Neoadjuvant gemcitabine and nab-paclitaxel for borderline resectable pancreatic cancers: intention-to-treat analysis compared with upfront surgery.
    J Hepatobiliary Pancreat Sci. 2021 Feb;28(2):143-155
  3. Ioka T, Furuse J, Ozaka M, Ishii H, et al; Hepatobiliary and Pancreatic Oncology Group (HBPOG) of Japan Clinical Oncology Group (JCOG).
    Randomized phase II study of chemoradiotherapy with versus without induction chemotherapy for locally advanced pancreatic cancer: Japan Clinical Oncology Group trial, JCOG1106.
    Jpn J Clin Oncol. 2021 Feb 8;51(2):235-243
  4. Yamamoto M, Yoshida M, Ozaka M, Takada T, et al.
    Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021.
    J Hepatobiliary Pancreat Sci. 2021 Jan;28(1):1-25
  5. Takahashi H, Ikeda M, Ozaka M, Furuse J, et al.
    Multicenter retrospective analysis of chemotherapy for advanced pancreatic acinar cell carcinoma: potential efficacy of platinum- and irinotecan-containing regimens.
    Pancreas. 2021 Jan 1;50(1):77-82
  6. Ueno M, Morinaga S, Sasahira N, Furuse J, et al.
    Tolerability of Nab-Paclitaxel Plus Gemcitabine as Adjuvant Setting in Japanese Patients With Resected Pancreatic Cancer: Phase I Study.
    Pancreas. 2021 Jan 1;50(1):83-88
  7. Umemoto K, Takahashi H, Yamada I, Ikeda M, et al.
    FOLFIRINOX in advanced pancreatic cancer patients with the double-variant type of UGT1A1 *28 and *6 polymorphism: a multicenter, retrospective study.
    Cancer Chemother Pharmacol. 2021 Mar;87(3):397-404
  8. Imaoka H, Ikeda M, Ozaka M, Furuse J, et al.
    Risk stratification and prognostic factors in patients with unresectable undifferentiated carcinoma of the pancreas.
    Pancreatology. 2021 Jun;21(4):738-745.
  9. Ueno M, Morizane C, Ozaka M, Furuse J, et al.
    A randomized, double-blind, phase II study of oral histone deacetylase inhibitor resminostat plus S-1 versus placebo plus S-1 in biliary tract cancers previously treated with gemcitabine plus platinum-based chemotherapy.
    Cancer Med. 2021 Mar;10(6):2088-2099.
  10. Takahashi Y, Sasahira N, Sasaki T, Ito H, et al.
    The role of stent placement above the papilla (inside-stent) as a bridging therapy for perihilar biliary malignancy: an initial experience.
    Surg Today. 2021 Nov;51(11):1795-1804.
  11. Ishigaki K, Nakai Y, Sasahira N, Isayama H, et al; Acquire Study Group.
    A Prospective Multicenter Study of EUS-guided Fine Needle Biopsy Using a 22-gauge Franseen Needle for Pancreatic Solid Lesions.
    J Gastroenterol Hepatol. 2021 Oct;36(10):2754-2761.
  12. Ueno M, Morizane C, Ozaka M, Furuse J, et al; members of the Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG).
    Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function: an exploratory analysis of JCOG1113.
    Sci Rep. 2021 Jun 18;11(1):12885.
  13. Toshima F, Watanabe R, Sasahira N, Sasaki T, Matsuyama M, Gabata T, et al.
    CT Abnormalities of the Pancreas Associated With the Subsequent Diagnosis of Clinical Stage I Pancreatic Ductal Adenocarcinoma More Than One Year Later: A Case-Control Study.
    AJR Am J Roentgenol. 2021 Dec;217(6):1353-1364.
  14. Ito G, Kawakami K, Ozaka M, Sasahira N, Hori S, et al.
    Risk factors for severe neutropenia in pancreatic cancer patients treated with gemcitabine/nab-paclitaxel combination therapy.
    PLoS One. 2021 Jul 14;16(7):e0254726.
  15. Hiyoshi Y, Mukai T, Sasaki T, Fukunaga Y, et al.
    Treatment outcome of laparoscopic surgery after self-expandable metallic stent insertion for obstructive colorectal cancer.
    Int J Clin Oncol. 2021 Nov;26(11):2029-2036.
  16. Lin Y, Nakatochi M, Sasahira N, Kikuchi S, et al.
    Glycoprotein 2 in health and disease: lifting the veil.
    Genes Environ. 2021 Dec 3;43(1):53.

2022年

(筆頭論文)

  1. Sasaki T, Takeda T, Sasahira N.
    Removal of a biliary self-expandable metal stent using the zipline technique for pancreatic cancer with duodenal stricture.
    Dig Endosc. 2022 Jan;34(1):e26-e27.
  2. Yamada I, Morizane C, Okusaka T, Mizusawa J, Kataoka T, Ueno M, Ikeda M, Okano N, Todaka A, Shimizu S, Mizuno N, Sekimoto M, Tobimatsu K, Yamaguchi H, Nishina T, Shirakawa H, Kojima Y, Oono T, Kawamoto Y, Furukawa M, Iwai T, Sudo K, Okamura K, Yamashita T, Kato N, Shioji K, Shimizu K, Nakagohri T, Kamata K, Ishii H, Furuse J; JCOG-HBPOG.
    The clinical outcomes of combination chemotherapy in elderly patients with advanced biliary tract cancer: an exploratory analysis of JCOG1113.
    Sci Rep. 2022 Jan 19;12(1):987.
  3. Kasuga A, Okamoto T, Udagawa S, Mori C, Mie T, Furukawa T, Yamada Y, Takeda T, Matsuyama M, Sasaki T, Ozaka M, Ueki A, Sasahira N.
    Molecular Features and Clinical Management of Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer.
    Int J Mol Sci. 2022 Jan 21;23(3):1205.
  4. Yamada Y, Sasaki T, Takeda T, Okamoto T, Takamatsu M, Mori C, Mie T, Furukawa T, Kasuga A, Matsuyama M, Ozaka M, Igarashi Y, Sasahira N.
    A Case of Multiple Gastric Metastases after Distal Pancreatectomy for Pancreatic Cancer.
    Intern Med. 2022 Sep 15;61(18):2741-2746.
  5. Takeda T, Sasaki T, Inoue Y, Okamoto T, Mori C, Mie T, Furukawa T, Yamada Y, Kasuga A, Matsuyama M, Ozaka M, Takahashi Y, Saiura A, Sasahira N.
    Early-onset pancreatic cancer: Clinical characteristics and survival outcomes.
    Pancreatology. 2022 May;22(4):507-515.
  6. Furukawa T, Takamatsu M, Inoue Y, Okamoto T, Mie T, Yamada Y, Takeda T, Kasuga A, Matsuyama M, Sasaki T, Ozaka M, Oba A, Ito H, Ono Y, Sato T, Takahashi YU, Saiura A, Sasahira N.
    Impact of Histological Features on Adjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Carcinoma.
    Anticancer Res. 2022 May;42(5):2645-2655.
  7. Sasaki T, Okamoto T, Yoshio T.
    Endoscopic removal of two intertwined esophageal stents from the stomach.
    Dig Endosc. 2022 Sep;34(6):e128-e129.
  8. Takeda T, Sasaki T, Mie T, Okamoto T, Mori C, Furukawa T, Yamada Y, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    Comparison of tube-assisted mapping biopsy with digital single-operator peroral cholangioscopy for preoperative evaluation of biliary tract cancer.
    Clin Endosc. 2022 Jul;55(4):549-557.
  9. Mie T, Sasaki T, Okamoto T, Takeda T, Mori C, Furukawa T, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    Treatment outcomes of nanoliposomal irinotecan as second-line chemotherapy after gemcitabine and nab-paclitaxel in metastatic and recurrent pancreatic cancer.
    Jpn J Clin Oncol. 2022 Dec 5;52(12):1399-1407.
  10. Kasuga A, Nojima M, Okamoto T, Ishitsuka T, Yamada M, Nakagawa H, Udagawa S, Mori C, Mie T, Furukawa T, Yamada Y, Takeda T, Matsuyama M, Sasaki T, Ozaka M, Sasahira N.
    Impact of the COVID-19 Pandemic on the Management and End-of-life Care of Unresectable Pancreatic Cancer.
    Intern Med. 2022 Dec 15;61(24):3641-3649.
  11. Mie T, Ozaka M, Okamoto T, Takeda T, Ushida Y, Mori C, Furukawa T, Yamada Y, Kasuga A, Matsuyama M, Sasaki T, Inoue Y, Takahashi YU, Sasahira N.
    CA19-9 Reduction After 4 Months of Treatment Is a Prognostic Factor for Locally Advanced Pancreatic Cancer.
    In Vivo. 2022 Nov-Dec;36(6):2844-2851.
  12. Yonekura C, Sasaki T, Mie T, Okamoto T, Takeda T, Furukawa T, Yamada Y, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    Endoscopic Transluminal Stent Placement for Malignant Afferent Loop Obstruction.
    J Clin Med. 2022 Oct 27;11(21):6357.
  13. Yamada M, Okamoto T, Sasahira N.
    Troubleshooting with a drill dilator for the stent-in-stent technique in malignant hilar biliary obstruction.
    Endoscopy. 2022 Dec;55(S 01):E189-E190.
  14. Mie T, Sasaki T, Takeda T, Okamoto T, Mori C, Furukawa T, Yamada Y, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    Diagnostic Yield of Serial Pancreatic Juice Aspiration Cytologic Examination With Brush Cytology for Pancreatic Ductal Stenosis.
    Pancreas. 2022 Sep 1;51(8):995-999.
  15. Ozaka M, Nakachi K, Kobayashi S, Ohba A, Imaoka H, Terashima T, Ishii H, Mizusawa J, Katayama H, Kataoka T, Okusaka T, Ikeda M, Sasahira N, Miwa H, Mizukoshi E, Okano N, Mizuno N, Yamamoto T, Komatsu Y, Todaka A, Kamata K, Furukawa M, Fujimori N, Katanuma A, Takayama Y, Tsumura H, Fukuda H, Ueno M, Furuse J; Hepatobiliary and Pancreatic Oncology Group of Japan Clinical Oncology Group (JCOG).
    A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407).
    Eur J Cancer. 2022 Dec 27;181:135-144.
  16. Okamoto T, Takeda T, Sasahira N. Endoscopic ultrasound-guided choledochoduodenostomy using a drill dilator. Endoscopy. 2022 Dec;55(S 01):E635-E636.

(共著論文)

  1. Osaki T, Lin Y, Sasahira N, Matsuyama M, Sasaki T, Kikuchi S, et al.
    Prevalence estimates of Helicobacter species infection in pancreatic and biliary tract cancers.
    Helicobacter. 2022 Feb;27(1):e12866.
  2. Yano T, Yoda Y, Sasaki T, Ono H, et al.
    Pivotal trial of a biodegradable stent for patients with refractory benign esophageal stricture.
    Esophagus. 2022 Jul;19(3):516-524.
  3. Takahashi Y, Sasaki T, Sasahira N, Saiura A, et al.
    Safety and efficacy of inside-stent as bridging therapy for malignant hilar biliary obstruction: single-centre prospective study. Br J Surg. 2022 Apr 19;109(5):468-469.
  4. Ishioka M, Yoshio T, Sasaki T, Sasahira N, Fujisaki J, et al.
    Safety and Efficacy of Self-Expandable Metallic Stent Placement Using Low Radial Force Stent for Malignant Dysphagia after Radiotherapy.
    Digestion. 2022;103(4):261-268.
  5. Ushida Y, Inoue Y, Mie T, Ozaka M, Sasaki T, Sasahira N, Takahashi Y, et al.
    Optimizing Indications for Conversion Surgery Based on Analysis of 454 Consecutive Japanese Cases with Unresectable Pancreatic Cancer Who Received Modified FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel: A Single-Center Retrospective Study.
    Ann Surg Oncol. 2022 Aug;29(8):5038-5050.
  6. Suzuki T, Masugi Y, Sasahira N, Takeda T, Fujishiro M, et al; GTK Pancreatic Cancer Study Group in Japan.
    KRAS variant allele frequency, but not mutation positivity, associates with survival of patients with pancreatic cancer.
    Cancer Sci. 2022 Sep;113(9):3097-3109.
  7. Nishida T, Sato S, Ozaka M, Kitagawa Y, et al; STAR ReGISTry Investigators.
    Long-term adjuvant therapy for high-risk gastrointestinal stromal tumors in the real world.
    Gastric Cancer. 2022 Sep;25(5):956-965.
  8. Kobayashi S, Suzuki M, Ozaka M, Ishii H, et al.
    Comparing the Efficacy and Safety of Gemcitabine plus Nab-Paclitaxel versus Gemcitabine Alone in Older Adults with Unresectable Pancreatic Cancer.
    Oncologist. 2022 Oct 1;27(10):e774-e782.
  9. Ohba A, Ueno H, Sasahira N, Ozaka M, Okusaka T, et al.
    Safety and efficacy of S-IROX (S-1, irinotecan and oxaliplatin combination therapy) in patients with advanced pancreatic cancer: A multicenter phase 1b dose-escalation and dose-expansion clinical trial.
    Eur J Cancer. 2022 Aug 12;174:40-47.
  10. Morizane C, Machida N, Ozaka M, Furuse J, et al; Japan Clinical Oncology Group (JCOG).
    Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System: The TOPIC-NEC Phase 3 Randomized Clinical Trial.
    JAMA Oncol. 2022 Oct 1;8(10):1447-1455.
  11. Ohmoto A, Hayashi N, Kasuga A, Takahashi S, et al.
    Druggable gene alterations in Japanese patients with rare malignancy.
    Neoplasia. 2022 Nov;33:100834.
  12. Yoshida Y, Kobayashi S, Ozaka M, Furuse J, et al.
    Efficacy of chemotherapy for patients with metastatic or recurrent pancreatic adenosquamous carcinoma: A multicenter retrospective analysis.
    Pancreatology. 2022 Dec;22(8):1159-1166.
  13. Takahara N, Nakai Y, Sasaki T, Koike K, et al.
    A prospective multicenter phase II study of FOLFIRINOX as a first-line treatment for patients with advanced and recurrent biliary tract cancer.
    Invest New Drugs. 2022 Feb;41(1):76-85.

2023年

(筆頭論文)

  1. Sasaki T, Takeda T, Yamada Y, Okamoto T, Mori C, Mie T, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    Long-term outcomes of endoscopic double stenting using an anti-reflux metal stent for combined malignant biliary and duodenal obstruction
    J Hepatobiliary Pancreat Sci. 2023 Jan;30(1):144-152.
  2. Takeda T, Sasaki T, Okamoto T, Kasuga A, Matsuyama M, Ozaka M, Inoue Y, Takahashi Y, Saiura A, Sasahira N. Outcomes of pancreatic cancer with liver oligometastasis
    J Hepatobiliary Pancreat Sci. 2023 Feb;30(2):229-239.
  3. Okamoto T, Sasaki T, Yoshio T, Mori C, Mie T, Furukawa T, Yamada Y, Takeda T, Kasuga A, Matsuyama M, Ozaka M, Fujisaki J, Sasahira N.
    Outcomes after partially covered self-expandable metal stent placement for recurrent duodenal obstruction
    Surg Endosc. 2023 Jan;37(1):319-328.
  4. Okamoto T, Sasaki T, Takahashi Y, Takamatsu M, Kanda H, Hiratsuka M, Matsuyama M, Ozaka M, Sasahira N.
    Perivascular epithelioid cell tumor (PEComa) of the cystic duct
    Clin J Gastroenterol. 2023 Feb;16(1):87-95.
  5. Okamoto T, Ishitsuka T, Sasahira N.
    Dilatation of hepaticojejunostomy anastomotic stricture with a drill dilator during balloon enteroscopy-assisted endoscopic retrograde cholangiopancreatography
    J Hepatobiliary Pancreat Sci. 2023 Jun;30(6):e41-e42.
  6. Mie T, Sasaki T, Sasahira N.
    Serial pancreatic juice aspiration cytologic examination with balloon-assisted enteroscopy in surgically altered anatomy
    Dig Endosc. 2023 Jan;35(1):e13-e15.
  7. Yamada M, Okamoto T, Sasahira N.
    Troubleshooting with a drill dilator for the stent-in-stent technique in malignant hilar biliary obstruction
    Endoscopy. 2023 Dec;55(S 01):E189-E190.
  8. Takeda T, Sasaki T, Okamoto T, Ishitsuka T, Yamada M, Nakagawa H, Mie T, Furukawa T, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    Impact of the Extent of Weight Loss before Administration on the Efficacy of Anamorelin in Advanced Pancreatic Cancer Patients with Cachexia
    Intern Med. 2023 Jul 1;62(13):1887-1893.
  9. Takeda T, Sasaki T, Yamada Y, Okamoto T, Mie T, Furukawa T, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    Long-term outcomes of duckbill-type anti-reflux metal stents versus conventional covered metal stents in reinterventions after covered biliary metal stent dysfunction in unresectable pancreatic cancer
    Surg Endosc. 2023 May;37(5):3498-3506.
  10. Takeda T, Sasaki T, Yamada Y, Okamoto T, Mie T, Furukawa T, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    The efficacy and safety of a duckbill-type anti-reflux metal stent as the initial metal stent for distal malignant biliary obstruction in unresectable pancreatic cancer
    DEN Open. 2023 Jan 9;3(1):e205.
  11. Ozaka M, Nakachi K, Kobayashi S, Ohba A, Imaoka H, Terashima T, Ishii H, Mizusawa J, Katayama H, Kataoka T, Okusaka T, Ikeda M, Sasahira N, Miwa H, Mizukoshi E, Okano N, Mizuno N, Yamamoto T, Komatsu Y, Todaka A, Kamata K, Furukawa M, Fujimori N, Katanuma A, Takayama Y, Tsumura H, Fukuda H, Ueno M, Furuse J; Hepatobiliary and Pancreatic Oncology Group of Japan Clinical Oncology Group (JCOG).
    A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407)
    Eur J Cancer. 2023 Mar;181:135-144.
  12. Mie T, Sasaki T, Takeda T, Okamoto T, Hamada T, Ishitsuka T, Yamada M, Nakagawa H, Furukawa T, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    Treatment Outcomes and Prognostic Factors of Gemcitabine Plus Nab-Paclitaxel as Second-Line Chemotherapy after Modified FOLFIRINOX in Unresectable Pancreatic Cancer
    Cancers (Basel). 2023 Jan 5;15(2):358.
  13. Takeda T, Sasaki T, Okamoto T, Ishitsuka T, Yamada M, Nakagawa H, Mie T, Furukawa T, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    Prognostic impact of osteosarcopenia in patients with advanced pancreatic cancer receiving gemcitabine plus nab-paclitaxel
    Pancreatology. 2023 Apr;23(3):275-282.
  14. Yamada Y, Sasaki T, Takeda T, Okamoto T, Mie T, Yonekura C, Furukawa T, Kasuga A, Matsuyama M, Ozaka M, Matsuda T, Igarashi Y, Sasahira N.
    Removal of Duckbill-type laser-cut anti-reflux metal stents: Clinical evaluation and in vitro study
    DEN Open. 2023 Feb 23;3(1):e217.
  15. Yamada M, Takeda T, Sasaki T, Okamoto T, Hamada T, Ishitsuka T, Nakagawa H, Mie T, Furukawa T, Kasuga A, Matsuyama M, Ozaka M, Kobara H, Masaki T, Sasahira N.
    Outcomes of Intraductal Placement of Covered Metal Stents for Unresectable Distal Malignant Biliary Obstruction
    J Clin Med. 2023 Mar 2;12(5):2001.
  16. Okamoto T, Takeda T, Sasahira N.
    Endoscopic ultrasound-guided choledochoduodenostomy using a drill dilator
    Endoscopy. 2023 Dec;55(S 01):E635-E636.
  17. Okamoto T, Sasaki T, Takeda T, Mie T, Mori C, Furukawa T, Yamada Y, Kasuga A, Matsuyama M, Ozaka M, Sasahira N.
    Rotatable sphincterotome as a rescue device for endoscopic retrograde cholangiopancreatography cannulation: a single-center experience
    Clin Endosc. 2024 Jan;57(1):96-104.
  18. Yamada M, Okamoto T, Sato Y, Takeda T, Mie T, Ishitsuka T, Nakagawa H, Matsuyama M, Sasaki T, Sasahira N.
    Late-onset hemobilia due to pseudoaneurysm rupture after endoscopic ultrasound-guided hepaticogastrostomy
    Clin J Gastroenterol. 2023 Oct;16(5):743-747.
  19. Takeda T, Okamoto T, Sasaki T, Hirai T, Ishitsuka T, Yamada M, Nakagawa H, Mie T, Furukawa T, Kasuga A, Ozaka M, Sasahira N.
    The impact of osteosarcopenia in patients with unresectable or recurrent biliary tract cancer receiving palliative chemotherapy
    Jpn J Clin Oncol. 2023 Nov 5;53(11):1051-1057.
  20. Takeda T, Sasaki T, Ichinose J, Inoue Y, Okamoto T, Mie T, Furukawa T, Kasuga A, Oba A, Matsuura Y, Nakao M, Ozaka M, Mun M, Takahashi Y, Sasahira N.
    Outcomes of lung oligometastasis in pancreatic cancer
    Jpn J Clin Oncol. 2023 Dec 7;53(12):1144-1152.
  21. Okamoto T, Takeda T, Sasaki T, Hamada T, Mie T, Ishitsuka T, Yamada M, Nakagawa H, Hirai T, Furukawa T, Kasuga A, Ozaka M, Sasahira N.
    Safety and Effectiveness of Chemotherapy in Elderly Biliary Tract Cancer Patients
    Curr Oncol. 2023 Jul 27;30(8):7229-7240.
  22. Matsuyama M, Okamoto T, Takeda T, Kasuga A, Sasaki T, Ozaka M, Sasahira N.
    Successful removal of a biliary metal stent using the stent-in-stent-in-stent technique
    Endoscopy. 2023 Dec;55(S01):E1025-E1026.
  23. Mie T, Sasaki T, Matsueda K, Okamoto T, Hirai T, Ishitsuka T, Yamada M, Nakagawa H, Furukawa T, Takeda T, Kasuga A, Ozaka M, Sasahira N.
    Ruptured cystic artery pseudoaneurysm after self-expandable metal stent placement for malignant biliary obstruction
    DEN Open. 2023 Oct 26;4(1):e304.
  24. Mie T, Sasaki T, Kobayashi K, Takeda T, Okamoto T, Kasuga A, Inoue Y, Takahashi Y, Saiura A, Sasahira N.
    Impact of preoperative self-expandable metal stent on benign hepaticojejunostomy anastomotic stricture after pancreaticoduodenectomy
    DEN Open. 2023 Oct 28;4(1):e307.
  25. Yamada M, Okamoto T, Sasahira N.
    Successful removal of a migrated plastic stent using a new endoscopic sheath
    Endoscopy. 2023 Dec;55(S01):E1250-E1251.
  26. Okamoto T, Takeda T, Mie T, Hirai T, Ishitsuka T, Yamada M, Nakagawa H, Furukawa T, Kasuga A, Sasaki T, Ozaka M, Sasahira N.
    Splenic Hilar Involvement and Sinistral Portal Hypertension in Unresectable Pancreatic Tail Cancer
    Cancers (Basel). 2023 Dec 15;15(24):5862.

(共著論文)

  1. Omiya K, Oba A, Sasaki T, Ozaka M, Sasahira N, Takahashi Y, et al.
    Serum DUPAN-2 could be an Alternative Biological Marker for CA19-9 Non-secretors with Pancreatic Cancer
    Ann Surg. 2023 Jun 1;277(6):e1278-e1283.
  2. Inokuma A, Takahara N, Sasaki T, Fujishiro M, et al.
    Comparison of novel large-bore and conventional-bore covered self-expandable metal stents for malignant gastric outlet obstruction: Multicenter, retrospective study
    Dig Endosc. 2023 Jan;35(1):111-121.
  3. Ishiwatari H, Kawabata T, Sasahira N, et al.
    Clinical Outcomes of Inside Stents and Conventional Plastic Stents as Bridge-to-Surgery Options for Malignant Hilar Biliary Obstruction
    Dig Dis Sci. 2023 Apr;68(4):1139-1147.
  4. Ono Y, Inoue Y, Sasaki T, Takeda T, Ozaka M, Sasahira N, Takahashi Y, et al.
    Analysis of prognostic factors for borderline resectable pancreatic cancer after neoadjuvant chemotherapy: the importance of CA19-9 decrease in patients with elevated pre-chemotherapy CA19-9 levels
    HPB (Oxford). 2023 Jan;25(1):100-108.
  5. Takahara N, Nakai Y, Sasaki T, Koike K, et al.
    A prospective multicenter phase II study of FOLFIRINOX as a first-line treatment for patients with advanced and recurrent biliary tract cancer
    Invest New Drugs. 2023 Feb;41(1):76-85.
  6. Nakayama I, Shinozaki E, Sasaki T, Yamaguchi K, et al.
    Implementation of microsatellite instability testing for the assessment of solid tumors in clinical practice
    Cancer Med. 2023 Apr;12(7):7932-7940.
  7. Nakachi K, Ikeda M, Takahashi Y, Furuse J, et al; Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG).
    Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial
    Lancet. 2023 Jan 21;401(10372):195-203.
  8. Okusaka T, Nakamura M, Ozaka M, et al; Committee for Revision of Clinical Guidelines for Pancreatic Cancer of the Japan Pancreas Society.
    Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis
    Int J Clin Oncol. 2023 Apr;28(4):493-511.
  9. Yamagata W, Fujisawa T, Sasaki T, Sasahira N, Isayama H, et al.
    Evaluation of the mechanical properties of current biliary self-expandable metallic stents: axial and radial force, and axial force zero border
    Clin Endosc. 2023 Sep;56(5):633-649.
  10. Kelley RK, Ueno M, Ozaka M, Vogel A, et al; KEYNOTE-966 Investigators.
    Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
    Lancet. 2023 Jun 3;401(10391):1853-1865.
  11. Kitano Y, Inoue Y, Takeda T, Ozaka M, Sasaki T, Sasahira N, Takahashi Y, et al.
    Clinical Efficacy of Neoadjuvant Chemotherapy with Gemcitabine plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma Compared with Upfront Surgery
    Ann Surg Oncol. 2023 Aug;30(8):5093-5102.
  12. Ishii S, Isayama H, Sasahira N, Sasaki T, Okamoto T, Suzuki A, et al.
    A pilot study of Spring Stopper Stents: Novel partially covered self-expandable metallic stents with anti-migration properties for EUS-guided hepaticogastrostomy
    Endosc Ultrasound. 2023 Mar-Apr;12(2):266-272.
  13. Mizuno N, Ioka T, Ozaka M, Furuse J, et al; Hepatobiliary and Pancreatic Oncology Group (HBPOG) of Japan Clinical Oncology Group (JCOG).
    Effect of systemic inflammatory response on induction chemotherapy followed by chemoradiotherapy for locally advanced pancreatic cancer: an exploratory subgroup analysis on systemic inflammatory response in JCOG1106
    Jpn J Clin Oncol. 2023 Jul 31;53(8):704-713.
  14. Masugi Y, Takamatsu M, Sasahira N, Takeda T, Sakamoto M, et al; GTK Pancreatic Cancer Study Group in Japan.
    Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and SMAD4 expression
    J Pathol Clin Res. 2023 Sep;9(5):339-353.
  15. Imaoka H, Ikeda M, Ozaka M, Nagano H, et al.
    Comprehensive review of undifferentiated carcinoma of the pancreas: from epidemiology to treatment
    Jpn J Clin Oncol. 2023 Aug 30;53(9):764-773.
  16. Oba A, Del Chiaro M, Sasaki T, Sasahira N, Takeyama Y, et al.
    "Conversion surgery" for locally advanced pancreatic cancer: A position paper by the study group at the joint meeting of the International Association of Pancreatology (IAP) & Japan Pancreas Society (JPS) 2022
    Pancreatology. 2023 Sep;23(6):712-720.
  17. Ishibashi R, Sasaki T, Saida Y, et al.
    A Japanese Prospective, Multicenter Study of Colonic Stenting for Palliation Using a High Axial Force Self-Expandable Metal Stent for Malignant Large Bowel Obstruction in 200 Patients
    J Clin Med. 2023 Aug 5;12(15):5134.
  18. Todaka A, Ozaka M, Boku N, et al.
    FOLFIRINOX in Pancreatic Cancer: Risk Factors for Febrile Neutropenia and Severe Neutropenia - Nationwide Study Analysis
    Anticancer Res. 2023 Sep;43(9):4115-4123.
  19. Aoki Y, Inoue Y, Sasahira N, Watanabe M, et al.
    Primary ovarian insufficiency associated with lenvatinib therapy in a patient with hepatocellular carcinoma: A case report
    Oncol Lett. 2023 Aug 31;26(4):450.
  20. Izumi A, Yoshio T, Sasaki T, Sasahira N, Fujisaki J, et al.
    Efficacy and Safety of Self-Expandable Metallic Stent Placement for Malignant Esophageal Fistula
    J Clin Med. 2023 Sep 8;12(18):5859.
  21. Ishiwatari H, Kawabata T, Sasahira N, et al.
    Endoscopic nasobiliary drainage versus endoscopic biliary stenting for preoperative biliary drainage in patients with malignant hilar biliary obstruction: Propensity score-matched multicenter comparative study
    Dig Endosc. 2024 Jun;36(6):726-734.
  22. Gotohda N, Nishida T, Ozaka M, Kitagawa Y, et al.
    Re-appraisal of the universal definition of tumor rupture among patients with high-risk gastrointestinal stromal tumors
    Ann Gastroenterol Surg. 2023 Apr 26;7(6):1021-1031.
  23. Tateai Y, Kawakami K, Ozaka M, Sasahira N, Yamaguchi M, et al.
    Factors associated with lenvatinib adherence in thyroid cancer and hepatocellular carcinoma
    PLoS One. 2023 Nov 16;18(11):e0294320.
  24. Mukai T, Nakai Y, Sasaki T, Yasuda I, et al; WONDERFUL Study Group in Japan.
    Early versus delayed EUS-guided drainage for postoperative pancreatic fluid collections: a systematic review and meta-analysis
    Surg Endosc. 2024 Jan;38(1):47-55.
  25. Imaoka H, Ikeda M, Ozaka M, Ueno M, et al.
    Development of a nomogram to predict survival in advanced biliary tract cancer
    Sci Rep. 2023 Dec 6;13(1):21548.

このページのTOPへ